Fresenius Medical Care Launches New €1 Billion Share Buyback After Cancelling 8.5% of Shares
FMS is trading near its 52-week low of $20.02 (8.1% above the low) on light trading volume (0.2× avg).
Summary
Fresenius Medical Care announced a new €1 billion share buyback program and cancelled 8.5% of its outstanding shares, significantly boosting shareholder value.
Key Events · Financing and Capital Events · FMS
-
Significant Share Capital Reduction
The Management Board resolved to cancel 24,848,819 treasury shares, reducing the share capital by approximately 8.5%. This directly increases earnings per share for existing shareholders.
-
New €1 Billion Share Buyback Program
The company announced a new share buyback program with a total volume of approximately €1 billion, to be executed over the next 12 months. This follows the successful completion of a previous €1 billion program and demonstrates a strong commitment to shareholder returns.
-
Dividend Increase Approved
Shareholders approved a dividend of €1.49 per share for fiscal year 2025, an increase from €1.44 per share in the prior year.
-
New Buyback Authorization
The Annual General Meeting granted a new five-year authorization for the Management Board to acquire and use treasury shares, enabling future capital return initiatives.
Analysis · FMS · Industrial Applications And Services
The company's Annual General Meeting approved a new authorization for share repurchases, leading to the immediate cancellation of 8.5% of outstanding shares from the recently completed buyback. This significant reduction in share count directly enhances earnings per share. Furthermore, the company announced a new €1 billion share buyback program, demonstrating a strong commitment to returning capital to shareholders and confidence in its financial strength and future growth.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 41.1% of the 372 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FMS was trading at $21.65 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $11.6B. The 52-week trading range was $20.02 to $29.71. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.